info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cystic Acne Companies

In the dynamic Cystic Acne Market, companies specialize in developing and delivering innovative solutions for severe acne management. These organizations focus on advanced treatments, medications, and skincare technologies, addressing the unique challenges posed by cystic acne to enhance skin health and overall well-being.

Cystic Acne Key Companies

 

Latest Cystic Acne Companies Update


Almirall's Seysara (sarecycline) Launched in the US in June 2021, this novel tetracycline-derived oral antibiotic specifically targets inflammatory and nodular acne, including cystic lesions.


Galderma's Epiduo Forte combination topical treatment of adapalene and benzoyl peroxide received an expanded FDA indication in February 2023 for moderate-to-severe acne, including inflammatory and cystic lesions.


Several promising therapies in clinical trials Dermavant Sciences and Inviragen are investigating novel oral and topical drugs targeting specific inflammatory pathways or bacterial strains involved in cystic acne development.


List of Cystic Acne Key Companies in the Market



  • GlaxoSmithKline plc (U.K)

  • Pfizer Inc. (U.S.)

  • Abbott Laboratories (U.S.)

  • Hexal AG (Germany)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Alma Lasers Inc. (Israel)

  • Bristol-Myers Squibb Company (U.S.)

  • GE Healthcare (U.K)

  • National Biological Corp. (U.S.)

  • Herbert Waldmann GmbH & Co. KG (Germany)

  • Sylvan Company (U.S.)

  • DUSA Pharmaceuticals Inc. (U.S.)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.